| Patents for C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687) |
|---|
| 04/13/2006 | WO2005087752A3 Substituted hydroxyethylamine aspartyl protease inhibitors |
| 04/13/2006 | WO2005049559A3 Novel piperidine-substituted indoles- or hetero-derivatives thereof and their use as modulators of chemokine receptor (ccr-3) |
| 04/13/2006 | US20060079695 Antibacterial oxalidinones |
| 04/13/2006 | US20060079693 Method and intermediate for preparing a prostaglandin F-type compound |
| 04/13/2006 | US20060079692 Synthesis of indole thiazole compounds as ligands for the Ah receptor |
| 04/13/2006 | US20060079688 Process for producing acid adduct salt of polyacidic base compound |
| 04/13/2006 | US20060079685 1-(4-Bromo-benzyl)-4-(4-isopropyl-phenyl)-6-propargyloxy-1H-quinazolin-2-one;osteoporosis, bone disorders, fractures, osteopathy, osteo-malacia, periodontal bone loss or bone loss due to arthritis or osteoarthritis; for promoting the release of parathyroid hormone |
| 04/13/2006 | US20060079684 Thrombin receptor antagonists |
| 04/13/2006 | US20060079683 Arylthiobenzylpiperidine derivatives |
| 04/13/2006 | US20060079527 Compounds such as 1-[4-(3,4-difluoro-phenyl) -piperazin-1 -yl]-3-{methyl-[2-(9H-xanthen-9-yl)-ethyl]-amino}-propan-1 -one in free base or acid addition salt form, for therapy of depression, anxiety and bipolar disorders |
| 04/13/2006 | US20060079525 antiinflammatory agent N-{[(2S)-4-(3,4-dichlorobenzyl)morpholin-2-yl]methyl}cyclopropane carboxamide; bronchitis, asthma, chronic obstructive pulmonary disease and rhinitis |
| 04/13/2006 | US20060079524 Amino substituted aryloxybenzylpiperidine derivatives |
| 04/13/2006 | US20060079523 N-[3-(1-{[4-(4-fluorophenylthio)phenyl]methyl}(4-piperidyl))-4-methylphenyl]-2-methylpropanamide; melatonin-concentrating hormone (MCH1) receptor ligand; antidepressant, anxiolytic, antidiabetic agent |
| 04/13/2006 | US20060079522 Amino substituted aryloxybenzylpiperidine derivatives |
| 04/13/2006 | US20060079521 Glycogen synthase kinase 3beta inhibitor, composition and process for the preparation thereof |
| 04/13/2006 | US20060079519 Heterocyclic-substituted benzamide derivatives, e.g., benzyl [2-(4-{1-[5-(5-tert-Butyl-3-methanesulfonylamino-2-methoxy-phenylcarbamoyl)-2-methyl-phenyl]-1H-1,2,3-triazol-4-yl}-2-phenyl-2H-pyrazol-3-yl)-ethyl]-carbamate; inhibit production of cytokines; useful for treating chronic inflammatory disease. |
| 04/13/2006 | US20060079518 Such as (S)-4-[2-(3-Chloro-phenyl)-2-hydroxy-ethylamino]-3-{6-[4-(2-methoxy-ethyl)-piperazin-1-yl]-4-methyl-1H-benzimidazol-2-yl}-1H-pyridin-2-one bis hydrochloride; anticancer agents; antiproliferative agents |
| 04/13/2006 | US20060079504 Selected CGRP antagonists, processes for preparing them and their use as pharmaceutical compositions |
| 04/13/2006 | US20060079498 ((2S,4S)-4-(4-(3-(Trifluoromethyl)phenyl)piperazin-1-yl)pyrrolidin-2-yl)-(3,3-difluoropyrrolidin-1-yl)-methanone dihydrochloride; dipeptidyl peptidase-IV inhibitor; diabetic complications including diabetic neuropathy, diabetic nephropathy, diabetic microangiopathy |
| 04/13/2006 | DE102004047254A1 Carbonylverbindungen Carbonyl compounds |
| 04/13/2006 | CA2791783A1 Semisynthesis process for the preparation of 10-deacetyl-n-debenzoyl-paclitaxel |
| 04/13/2006 | CA2583326A1 Receptor function regulating agent |
| 04/13/2006 | CA2582356A1 Novel benzimidazole derivatives useful as selective androgen receptor modulators (sarms) |
| 04/13/2006 | CA2582347A1 Novel benzimidazole derivatives useful as selective androgen receptor modulators (sarms) |
| 04/13/2006 | CA2581921A1 Benzoxazine and quinoxaline derivatives and uses |
| 04/13/2006 | CA2581638A1 Substituted 2h-1,3-benzoxazin-4(3h)-ones |
| 04/13/2006 | CA2579091A1 Isoxazoline derivatives and their use as herbicides |
| 04/12/2006 | EP1644370A2 Tetrahydroquinoline derivatives as cannabinoid receptor modulators |
| 04/12/2006 | EP1644369A2 Arylamine-substituted quinazolinone compounds |
| 04/12/2006 | EP1644367A1 Immunosuppressant compounds and compositions |
| 04/12/2006 | EP1644363A1 Triheterocyclic compounds, compositions, and methods for treating cancer or viral diseases |
| 04/12/2006 | EP1644358A2 Biaryl piperazinyl-pyridine analogues |
| 04/12/2006 | EP1644357A1 Trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto |
| 04/12/2006 | EP1644353A1 Amide-substituted 1,2,4-triazin-5(2h)-ones for the treatment of chronically inflammatory diseases |
| 04/12/2006 | EP1644335A1 Tetrahydroquinoline derivatives as cannabinoid receptor modulators |
| 04/12/2006 | EP1643998A1 Dual nk1/nk3 antagonists for treating schizophrenia |
| 04/12/2006 | EP1643960A2 Arylsulfonamide derivatives |
| 04/12/2006 | EP1476444B1 Heterocyclic compounds possessing affinity at 5ht1-type receptors and use thereof in therapy |
| 04/12/2006 | EP1404671B1 Macrocycles useful in the treatment of alzheimer's disease |
| 04/12/2006 | EP1343771B1 3-ox(adi)azolylpropanohydroxamic acids useful as procollagen c-proteinase inhibitors |
| 04/12/2006 | EP1336605B1 Substituted phenol derivatives or salts thereof as inhibitors of coagulation factor x |
| 04/12/2006 | EP1302466B1 Benzoxazole compound, process for producing the same, and herbicide |
| 04/12/2006 | EP1254119B1 Pyrimidine derivatives as selective inhibitors of cox-2 |
| 04/12/2006 | EP1005356B1 Novel antibacterial agents |
| 04/12/2006 | EP1003736B1 Substituted 4-benzoyl-pyrazoles |
| 04/12/2006 | CN1759116A Pyridyloxymethyl and benzisoxazole azabicyclic derivatives |
| 04/12/2006 | CN1759115A Synthesis of epothilones, intermediates thereto, analogues and uses thereof |
| 04/12/2006 | CN1759114A Heterocyclic N-aryl carboxamides as cytokine inhibitors |
| 04/12/2006 | CN1759112A Benzimidazole derivatives and their use for modulating the GABA- SB A /SB receptor complex |
| 04/12/2006 | CN1759111A Imidazol-4-yl-ethynyl-pyridine derivatives |
| 04/12/2006 | CN1757634A Intermidiate for preparing 1,2-oxygen nitrogen heterocyclic-2-alkene acylbenzene and its preparation |
| 04/12/2006 | CN1250544C Pyridoarylphenyl oxazolidinone antibacterials and related compositions and methods |
| 04/12/2006 | CN1250542C 2-(1H-indol-3-yl)-2-oxo-acetamides with antitumor activity |
| 04/12/2006 | CN1250539C Intermediate for preparing 1-[halogenarylradical] heterocyclic pesticide compound |
| 04/12/2006 | CN1250531C Novel compounds |
| 04/12/2006 | CN1250526C Pyrrole substituted 2-indolinone protein kinase inhibitors |
| 04/11/2006 | US7026476 Intermediate arylamine compounds |
| 04/11/2006 | US7026339 Inhibitors of HCV NS5B polymerase |
| 04/11/2006 | US7026336 4-pyridinylimidazol-2-ylhydrocarbyl amine, (thio)urea, carbamic acid or sulfonamide derivatives, e.g., (2-(4-(4-Chloro-3-methoxy-phenyl)-5-pyridin-4-yl-1H-imidazol-2-yl)-2-methyl-propyl)-carbamic acid tert-butyl ester; Raf kinase inhibitors for the treatment of neurotraumatic diseases |
| 04/11/2006 | US7026323 N-(naphth-2-ylaminocarbonylacetyl)- or N-(naphth-2-ylcarbonylamino- acetyl)- piperazine derivatives, e.g., 2-[((4-(ethoxycarbonyl)piperazin-1-yl)carbonylmethyl)carbonyl]aminonaphthalene; useful as antithrombotic agents |
| 04/11/2006 | US7026314 Psychological disorders, antidepressants, anxiolytic agents, eating disorders; serotonin receptors antagonist |
| 04/11/2006 | CA2281702C (4-piperidinyl)-1h-2-benzopyran derivatives useful as antipsychotic agents |
| 04/11/2006 | CA2162382C Intercalators having affinity for dna and methods of use |
| 04/06/2006 | WO2006036994A2 Modulators of crth2, cox-2 and faah |
| 04/06/2006 | WO2006036015A2 6- (pyridinyl) -4-pyrimidone derivates as tau protein kinase 1 inhibitors |
| 04/06/2006 | WO2006035967A1 Pyridine derivatives and their use as medicaments for treating diseases related to mch receptor |
| 04/06/2006 | WO2006035283A1 Oxazolidinone derivatives as antimicrobials |
| 04/06/2006 | WO2006035068A2 Hiv inhibiting 5-carbo- or heterocyclic substituted pyrimidines |
| 04/06/2006 | WO2006035067A2 Hiv inhibiting 5-heterocyclyl pyrimidines |
| 04/06/2006 | WO2006035021A1 Benzoxazine compounds derivated from phenolphtalein having flame-retardant properties and a process for their preparation |
| 04/06/2006 | WO2006034833A1 Cyclic diarly ureas suitable as tyrosine kinase inhibitors |
| 04/06/2006 | WO2006034822A1 Novel substituted thiophencarboxylic acid amides, production thereof and use thereof as medicaments |
| 04/06/2006 | WO2006034804A1 Indozolone derivatives as 11b-hsd1 inhibitors |
| 04/06/2006 | WO2006034789A1 Proline derivatives |
| 04/06/2006 | WO2006034769A1 Carbonyl compounds usable as coagulation factor xa inhibitors |
| 04/06/2006 | WO2006004793A3 Hetero isonipecotic modulators of vanilloid vr1 receptor |
| 04/06/2006 | WO2005068442A3 Isoxazole derivatives and their use as cyclooxygenase inhibitors |
| 04/06/2006 | US20060074244 Pyridinyl substituted (1,2,3,)triazoles as inhibitors of the tgf-beta signalling pathway |
| 04/06/2006 | US20060074243 Hydroxamic acid and amide compounds and their use as protease inhibitors |
| 04/06/2006 | US20060074237 Pyridines |
| 04/06/2006 | US20060074128 Substituted 2-phenyl benzofurans as estrogenic agents |
| 04/06/2006 | US20060074123 Cyclic AMP-specific phosphodiesterase inhibitors |
| 04/06/2006 | US20060074116 3-(Heteroarylamino)methylene-1, 3-dihydro-2H-indol-2-ones as kinase inhibitors |
| 04/06/2006 | US20060074112 N-aryl (thio) anthranilic acid amide derivatives, their preparation and their use as VEGF receptor tyrosine kinase inhibitors |
| 04/06/2006 | US20060074085 Bcl-XL inhibitors; N-{[4-({(1R)-5-(dimethylamino)-1-[(phenylthio)methyl]pentyl}amino)-3-nitrophenyl]sulfonyl}-4-(4-fluorophenyl)piperidine-1-carboxamide; useful for promoting apoptosis; Anticancer agents; autoimmune diseases; antiinflammatory agents |
| 04/06/2006 | US20060074084 Inhibitors of soluble adenylate cyclase |
| 04/06/2006 | US20060074083 Cyclic and acyclic propenones for treating CNS disorders |
| 04/06/2006 | US20060074082 (Arylamidoaryl)cyanoguanidine compounds |
| 04/06/2006 | US20060074075 including cystic fibrosis transmembrane conductance regulator ("CFTR"), used for treating genetic disorders; respiratory system disorders |
| 04/06/2006 | US20060074072 2-[3-(4-chlorophenyl)ureido] N-[4-(2-oxo-2H-pyridin-1-yl)phenyl]-4-methanesulfonylbutyramide; prophylaxis and/or therapy of thromboembolic diseases and for the treatment of tumors |
| 04/06/2006 | US20060073971 3-(2,6-Dichlorophenyl)-4-[(3-pyridyl)hydroxymethyl]-5-trimethysilylisoxazole; crop protection agents to combat or prevent fungal infestations, or to control other pests such as weeds, insects, or acarids |
| 04/06/2006 | DE102004047272A1 Inhibitoren der löslichen Adenylatzyklase Inhibitors of soluble adenylate cyclase |
| 04/06/2006 | CA2582046A1 Halocombstatins and methods of synthesis thereof |
| 04/06/2006 | CA2581737A1 Proline derivatives |
| 04/06/2006 | CA2581732A1 Carbonyl compounds usable as coagulation factor xa inhibitors |
| 04/06/2006 | CA2581580A1 Novel substituted thiophencarboxylic acid amides, production thereof and use thereof as medicaments |
| 04/06/2006 | CA2581179A1 6-(pyridinyl)-4 pyrimidone derivatives as tau protein kinase 1 inhibitors |
| 04/06/2006 | CA2577467A1 Hiv inhibiting 5-heterocyclyl pyrimidines |
| 04/06/2006 | CA2577185A1 Cyclic diarly ureas suitable as tyrosine kinase inhibitors |
| 04/06/2006 | CA2573976A1 Hiv inhibiting 5-carbo- or heterocyclic substituted pyrimidines |